A choice of death - The signal-transduction of immune-mediated beta-cell apoptosis

Diabetologia

Volumn 44, Issue 12, 2001, Pages 2115-2133

  Eizirik, D L ^a   Mandrup Poulsen, T ^b  

^a DIABETES RESEARCH CENTER   (Belgium)

^b STENO DIABETES CENTER   (Denmark)

Author keywords

Apoptosis; Beta cell; Diabetes mellitus; Interferon ; Interleukin 1; Nitric oxide

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; STAT1 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

CELL DEATH; CELL DESTRUCTION; CELL FUNCTION; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVATION; GENE FUNCTION; GENETIC TRANSCRIPTION; HUMAN; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; DIABETES MELLITUS, TYPE 1; IMMUNE SYSTEM; ISLETS OF LANGERHANS; SIGNAL TRANSDUCTION;

EID: 0035668779     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250100021     Document Type: Review

References (181)

1. β-cell dysfunction and death
2. Apoptosis and the pathogenesis of IDDM: A question of life and death
3. From bench to clinic with apoptosis-based therapeutic agents
4. Perspective: Postnatal pancreatic beta cell growth
5. Neonatal beta-cell apoptosis: A trigger for autoimmune diabetes?
6. Type 2 diabetes and beta cell apoptosis
7. β-cell apoptosis and defense mechanisms: Lessons from type 1 diabetes
8. β-cell apoptosis: Stimuli and signaling
9. Morphologic and biochemical hallmarks of apoptosis
10. Corpse clearance defines the meaning of cell death
11. β-cell apoptosis in T cell-mediated autoimmune diabetes
12. Apoptosis and beta-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes
13. Apoptosis is the mode of β-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse
14. Beta-cell apoptosis in an accelerated model of autoimmune diabetes
15. Apoptosis of pancreatic β-cells detected in accelerated diabetes of NOD mice: No role of Fas-Fas ligand interaction in autoimmune diabetes
16. Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model
17. Apoptosis and remodelling of beta cells by paracrine interferon-γ without insulitis in transgenic mice
18. The role of interleukin-1 in the pathogenesis of IDDM
19. Apoptosis and disease progression in the spontaneously diabetic BB/S rat
20. Nitric oxide primes pancreatic beta cells for Fas-mediated destruction in insulin-dependent diabetes mellitus
21. Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset Type I diabetes mellitus
22. + T-cell-mediated insulin-dependent diabetes mellitus (IDDM)
23. Transgenes and knockout mutations in animal models of type 1 diabetes and multiple sclerosis
24. + T cells in autoimmune diabetes through the use of TCR transgenic mice
25. Islet-specific T cell clones transfer diabetes to nonobese diabetic (NOD) F1 mice
26. + T cells in the destruction of islet grafts by spontaneously diabetic mice
27. Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions
28. + T cells in the initiation of insulin-dependent diabetes mellitus
29. + CTL clones in β2 microglobulin-deficient mice
30. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent
31. Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor α chain gene rearrangement
32. Administration of silica prevents diabetes in BB-rats
33. Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages
34. Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: Defective regulation of cytokine receptors and protein kinase C
35. Splenic macrophages from the NOD mouse are defective in the ability to present antigen
36. B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice
37. Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta- cell destruction in NOD mice
38. The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice
39. + T-cells in T-cell receptor transgenic NOD mice
40. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice
41. A role for macrophages in the pathogenesis of type 1 diabetes
42. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells
43. Virus-induced autoimmune diabetes: Most β-cells die through inflammatory cytokines and not perforin from autoreactive (anti-viral) cytotoxic T-lymphocytes
44. + T lymphocytes in transgenic nonobese diabetic mice
45. + T lymphocytes
46. Interferon-γ is essential for destruction of β cells and development of insulin-dependent diabetes mellitus
47. Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue
48. + T cell-mediated insulin-dependent diabetes mellitus
49. A mouse CD8 T cell-mediated acute autoimmune diabetes independent of the perforin and Fas cytotoxic pathways: Possible role of membrane TNF
50. Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice
51. Mouse islet cell lysis mediated by interleukin-1-induced Fas
52. β-cell destruction in NOD mice correlates with Fas (CD95) expression on β-cells and proinflammatory cytokine expression in islets
53. Fas ligand-mediated mechanisms are involved in autoimmune destruction of islet beta cells in non-obese diabetic mice
54. The role of Fas in autoimmune diabetes
55. Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice
56. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction
57. Significant role for Fas in the pathogenesis of autoimmune diabetes
58. Evidence that β cell death in the nonobese diabetic mouse is Fas independent
59. Mechanisms of β-cell death in diabetes: A minor role for CD95
60. In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor α
61. Inhibition of autoimmune diabetes by Fas ligand: The paradox is solved
62. TNF receptor 1-dependent β cell toxicity as an effector pathway in autoimmune diabetes
63. Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor α leads to autoimmunity in transgenic mice
64. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma
65. Induction of type I diabetes by interferon-α in transgenic mice
66. Inflammation but not autoimmunity occurs in transgenic mice expressing constitutive levels of interleukin-2 in islet beta cells
67. Local production of human IL-6 promotes insulitis but retards the onset of insulin-dependent diabetes mellitus in non-obese diabetic mice
68. Expression of a tumor necrosis factor α transgene in murine pancreatic βcells results in severe and permanent insulitis without evolution towards diabetes
69. Insulitis in transgenic mice expressing tumor necrosis factor β (lymphotoxin) in the pancreas
70. Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans
71. Local expression of transgene encoded TNFα in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells
72. Local expression of TNFα in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens
73. The temporal importance of TNFα expression in the development of diabetes
74. Genetic requirements for acceleration of diabetes in non-obese diabetic mice expressing interleukin-2 in islet β-cells
75. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice
76. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse
77. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice
78. MHC antigen induction by interferon-γ on cultured mouse pancreatic βcells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice
79. IFN-γ action on pancreatic β cells causes class I MHC upregulation but not diabetes
80. Postnatal anti-interferon-γ treatment prevents pancreatic inflammation in transgenic mice with β-cell expression of interferon-γ
81. Dual role of interferon-γ signaling pathway in sensitivity of pancreatic beta cells to immune destruction
82. Genetic absence of γ-interferon delays but does not prevent diabetes in NOD mice
83. Interferon-γ impacts at multiple points during the progression of autoimmune diabetes
84. Interferon-γ receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice
85. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice
86. A targeted mutation in the IL-4Rα gene protects mice against autoimmune diabetes
87. Interleukin-4 deficiency does not exacerbate disease in NOD mice
88. Protection of nonobese diabetic mice from diabetes by gene(s) closely linked to IFN-gamma receptor loci
89. IL-4 triggers autoimmune diabetes by increasing self-antigen presentation within the pancreatic islets
90. Some misconceptions about understanding autoimmunity through experiments with knock-outs
91. Cytokines cause functional and structural damage to isolated islets of Langerhans
92. Is there a role for nitric oxide in β-cell dysfunction and damage in IDDM?
93. Nicotinamide protects human beta cells against chemically-induced necrosis, but not against cytokine-induced apoptosis
94. The role of interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic β-cells
95. Cytokines induce apoptosis in β-cells isolated from mice lacking the inducible isoform of nitric oxide synthase (iNOS-/-)
96. Distinction between interleukin-1-induced necrosis and apoptosis of islet cells
97. Double-stranded RNA induces β-cell Fas mRNA expression and increases cytokine-induced β-cell apoptosis
98. Nitric oxide production and Fas surface expression mediate two independent pathways of cytokine-induced murine beta-cell damage
99. Cytokines induce both necrosis and apoptosis via a common bcl-2-inhibitable pathway in rat insulin-producing cells
100. TNF-α and IFN-γ potentiate the deleterious effects of IL-1 beta on mouse pancreatic islets mainly via generation of nitric oxide
101. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans
102. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation
103. Human pancreatic islet β-cell destruction by cytokines is independent of nitric oxide production
104. Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells
105. Differences in the expression of heat-shock proteins and antioxidant enzymes between human and rodent pancreatic islets: Implications for the pathogenesis of insulin-dependent diabetes mellitus
106. Natural resistance of human beta cells toward nitric oxide is mediated by heat shock protein 70
107. Heat shock proteins as cellular life-guards
108. The role of viruses in Type I diabetes: Two distinct cellular and molecular pathogenic mechanisms of virus-induced diabetes in animals
109. Mechanisms of Coxsackievirus-induced damage to human pancreatic β-cells
110. When two strands are better than one: The mediators and modulators of the cellular responses to double-stranded RNA
111. Effect of interferon and double-stranded RNA on β-cell function in mouse islets of Langerhans
112. Double-stranded RNA inhibits β-cell function and induces islet damage by stimulating β-cell production of nitric oxide
113. Protein kinase R (PKR) is upregulated by cytokines in rat islets and RIN-cells
114. Double-stranded RNA-dependent protein kinase is not required for double-stranded RNA-induced nitric oxide synthase expression or nuclear factor-ℜB activation by islets
115. Mechanisms of beta-cell death in response to double-stranded (ds) RNA and interferon-gamma: dsRNA-dependent protein kinase apoptosis and nitric oxide-dependent necrosis
116. Involvement of double-stranded RNA-activated protein kinase in the synergistic activation of nuclear factor-ℜB by tumor necrosis factor-α and γ-interferon in preneuronal cells
117. PKR stimulates NF-κB irrespective of its kinase function by interacting with the IℜB kinase complex
118. Interleukin-1
119. Dominant negative MyD88 proteins inhibit interleukin-1β /interferon-γ-mediated induction of nuclear factor ℜB-dependent nitrite production and apoptosis in β cells
120. The Rel/NF-ℜB signal transduction pathway: Introduction
121. Phosphatidylinositol 3-kinase in interleukin 1 signaling. Physical interaction with the interleukin 1 receptor and requirement in NFℜB and AP-1 activation
122. The interleukin 1 receptor: Ligand interactions and signal transduction
123. Biologic functions of the IFN-γ receptors
124. Ischemia-induced STAT-1 expression and activation play a critical role in cardiomyocyte apoptosis
125. How cells respond to interferons
126. TNF-induced signaling in apoptosis
127. Protein kinase cascades in intracellular signalling by interleukin-I and tumour necrosis factor
128. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways
129. Signal transduction by the JNK group of MAP kinases
130. Activation of transcription factor NFℜB and p38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways
131. Interleukin-1β-induced rat pancreatic islet nitric oxide synthesis requires both the p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases
132. TNFα and IFNγ potentiate IL-1β induced mitogen activated protein kinase activity in rat pancreatic islets of Langerhans
133. Activation of extracellular signal-regulated kinase (ERK)1/2 contributes to cytokine-induced apoptosis in purified rat pancreatic β-cells
134. Interleukin-1β-induced ceramide and diacylglycerol generation may lead to activation of the c-Jun NH2-terminal kinase and the transcription factor ATF-2 in the insulin-producing cell line RINm5F
135. The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic beta-cells
136. IB1 reduces cytokine-induced apoptosis of insulin-secreting cells
137. Cell-permeable peptide inhibitors of JNK: Novel blockers of beta-cell death
138. Glucose potentiates IL-1β-induced p38 mitogen-activated protein kinase activity in rat pancreatic islets of Langerhans
139. Interleukin-1-beta induced p38 and c-jun-N-terminal kinase activities in isolated rat pancreatic islets is nitric oxide dependent
140. A low voltage-activated Ca2 + current mediates cytokine-induced pancreatic beta-cell death
141. Calcium signalling via L-Type calcium channels mediates IL-1-induced activities of C-Jun N-terminal kinase and p38 in pancreatic beta-cells
142. High density synthetic oligonucleotide arrays
143. Genomics, gene expression and DNA arrays
144. Gene expression profiling: Monitoring transcription and translation products using DNA microarrays and proteomics
145. Identification of novel IL-1β induced genes in pancreatic β-cells by high density oligonucleotide arrays
146. Identification of novel cytokine induced genes in pancreatic β-cells by high density oligonucleotide arrays
147. Massive parallel gene expression profiling of RINm5F pancreatic islet β-cells stimulated with interleukin-1β
148. Cytokine- or chemically derived nitric oxide alters the expression of proteins detected by two-dimensional gel electrophoresis in neonatal rat islets of Langerhans
149. Proteome analysis of IL-1β induced changes in protein expression in rat islets of Langerhans
150. Activators and target genes of Rel/NF-ℜB transcription factors
151. NF-ℜB: A key role in inflammatory diseases
152. NF-ℜB in neuronal plasticity and neurodegenerative disorders
153. The harmony of the spheres: Inducible nitric oxide synthase and related genes in pancreatic beta cells
154. Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells
155. NF-ℜB is required for cytokine-induced manganese superoxide dismutase expression in insulin-producing cells
156. Cytokine-induction of Fas gene expression in insulin-producing cells requires the transcription factors NK-ℜB and C/EBP
157. Inhibition of cytokine-induced NF-ℜB activation by adenovirus-mediated expression of a nuclear factor ℜB super-repressor prevents β-cell apoptosis
158. Protection of human islets from the effects of interleukin-1beta by adenoviral gene transfer of an IℜB repressor
159. Expression of a dominant negative inhibitor of NF-ℜB protects MIN6 beta-cells from cytokine-induced apoptosis
160. A20 inhibits cytokine-induced apoptosis and nuclear factor ℜB- dependent gene activation in islets
161. Cytokines and STAT signaling
162. Requirements for transcription factor IRF-1 in NO synthase induction in macrophages
163. Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking interferon regulatory factor-1
164. IFN-γ/TNF-α synergism as the final effector in autoimmune diabetes: A key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death
165. Effect of nutrients, hormones and serum on survival of rat islet beta cells in culture
166. Interleukin-1β-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase
167. Interleukin-1 induced impairment in pancreatic islet oxidative metabolism of glucose is potentiated by tumor necrosis factor
168. Biochemical and molecular actions of interleukin-1 on pancreatic β-cells
169. Interleukin-1β-induced alteration in a β-cell phenotype can reduce cellular sensitivity to conditions that cause necrosis but not to cytokine-induced apoptosis
170. Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes
171. Control of islet growth by c-myc in vivo: Diabetes may be the price for avoiding cancer
172. Transcribing pancreas
173. Beta-cell maturation leads to in vitro sensitivity to cytotoxins
174. Cytokine-mediated apoptosis in rat β-cells is preceded by downregulation of Bcl-2 and Bax-omega expression
175. Bovine islets are less susceptible than human islets to damage by human cytokines
176. Evidence for the involvement of cGMP and protein kinase G in nitric oxide-induced apoptosis in the pancreatic B-cell line, HIT-T15
177. NO induces a cGMP-independent release of cytochrome c from mitochondria which precedes caspase 3 activation in insulin producing RINm5F cells
178. Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects β-cells from cytokine-induced destruction
179. SOCS-1 protein prevents JAK/STAT-dependent inhibition of β cell insulin gene transcription and secretion in response to IFN-γ
180. Nitric-oxide induced apoptosis in pancreatic β-cells is mediated by the endoplasmic reticulum stress pathway